NCT06329284View on ClinicalTrials.gov

Midkine Role With Deregulated Oxidative and Immune Milieu in Induction of Preeclampsia

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

September 15, 2023

Study Completion Date

December 15, 2023

Conditions
Pre-Eclampsia
Interventions
DIAGNOSTIC_TEST

ELISA

ELISA estimation of serum Midkine, tumor necrosis factor Alfa, superoxide dismutase, malondialdehyde, placental growth factor and placental soluble fms-like tyrosine kinase 1

Trial Locations (1)

13511

Banha University, Banhā

All Listed Sponsors
lead

Benha University

OTHER